HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Liability, Current in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Heron Therapeutics, Inc. /De/ quarterly Operating Lease, Liability, Current history and growth rate from Q1 2019 to Q2 2024.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Liability, Current for the quarter ending June 30, 2024 was $3.19M, a 23.8% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.19M +$614K +23.8% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $3.14M +$375K +13.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.08M +$381K +14.1% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $3M +$379K +14.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.58M +$31K +1.22% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.76M +$278K +11.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.69M +$277K +11.5% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $2.62M -$631K -19.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $2.55M -$613K -19.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $2.48M -$597K -19.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.42M -$580K -19.4% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $3.25M +$339K +11.6% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $3.16M +$332K +11.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.08M +$326K +11.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $3M +$1.07M +55.6% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $2.91M +$1.19M +69.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.83M +$1.11M +64.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $2.76M +$723K +35.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $1.93M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $1.72M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.72M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $2.03M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.